Back
United Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55
UTHR
United Therapeutics
Last Price:
$312.92
Seasonality Move:
8.74%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing buying pressure, which is a positive indicator for future bullish movement.
United Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 303.97 | Buy |
| 20-day SMA: | 298.53 | Buy |
| 50-day SMA: | 296.4 | Buy |
| 200-day SMA: | 328.48 | Sell |
| 8-day EMA: | 292.46 | Buy |
| 20-day EMA: | 218.81 | Buy |
| 50-day EMA: | 121.26 | Buy |
| 200-day EMA: | 36.35 | Buy |
United Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 78.13 | Buy |
| Relative Strength Index (14 RSI): | 60.49 | Buy |
| Chaikin Money Flow: | 521153 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (290.26 - 305.94) | Buy |
| Bollinger Bands (100): | (287.16 - 311.22) | Buy |
United Therapeutics Technical Analysis
| Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for United Therapeutics Stock
Is United Therapeutics Stock a Buy?
-
United Therapeutics share price is 312.06 while UTHR 8-day simple moving average is 303.97, which is a Buy signal.
-
The stock price of UTHR is 312.06 while United Therapeutics 20-day SMA is 298.53, which makes it a Buy.
-
United Therapeutics 50-day simple moving average is 296.40 while UTHR share price is 312.06, making it a Buy technically.
-
UTHR stock price is 312.06 and United Therapeutics 200-day simple moving average is 328.48, creating a Sell signal.
UTHR Technical Analysis vs Fundamental Analysis
Buy
55
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics a Buy or a Sell?
-
United Therapeutics stock is rated a BuyThe current United Therapeutics [UTHR] share price is $312.06. The Score for UTHR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
United Therapeutics Stock Info
Market Cap:
14.1B
Price in USD:
312.06
Share Volume:
587.1K
United Therapeutics 52-Week Range
52-Week High:
417.82
52-Week Low:
266.98
Buy
55
United Therapeutics (UTHR)
is a Buy
United Therapeutics Share Price Forecast
-
What is the United Therapeutics stock price today?The United Therapeutics stock price is 312.06 USD today.
-
Will UTHR stock go up or go down?United Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is United Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, United Therapeutics is not overvalued.
Is United Therapeutics Stock a Buy?
-
United Therapeutics share price is 312.06 while UTHR 8-day exponential moving average is 292.46, which is a Buy signal.
-
The stock price of UTHR is 312.06 while United Therapeutics 20-day EMA is 218.81, which makes it a Buy.
-
United Therapeutics 50-day exponential moving average is 121.26 while UTHR share price is 312.06, making it a Buy technically.
-
UTHR stock price is 312.06 and United Therapeutics 200-day simple moving average is 36.35, creating a Buy signal.
Fundamental Analysis of United Therapeutics
Is United Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.65 per share, an increase next quarter of $0.87 per share, an increase this year of $1.90 per share, and an increase next year of $1.42 per share.
Technical Analysis of United Therapeutics
Should I short United Therapeutics stock?
-
UTHR Moving Average Covergence Divergence (MACD) indicator is 78.13, suggesting United Therapeutics is a Buy
-
United Therapeutics Relative Strength Index (RSI) is 60.49, which suggest United Therapeutics is overbought
-
The Bollinger Bands (25) for United Therapeutics is (290.26 - 305.94), which suggest United Therapeutics is a Buy
-
The Bollinger Bands (100) for United Therapeutics is (287.16 - 311.22), which suggest United Therapeutics is a Buy
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.